inositol and rifampin
inositol has been researched along with rifampin in 10 studies
Research
Studies (10)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 4 (40.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Aguilera, JA; Anderberg, SJ; Av-Gay, Y; delCardayre, SB; Fahey, RC; Newton, GL; Oh, NN; Unson, MD | 1 |
Melchor, JP; Van Nostrand, WE | 1 |
Buchmeier, NA; Fahey, RC; Koledin, T; Newton, GL | 1 |
Hernick, M | 1 |
Annunziata, MC; Donnarumma, M; Fabbrocini, G; Marasca, C; Palma, M; Vastarella, M | 1 |
Chakrapani, G; Doble, M; Mitra, K; Ravindran, R | 1 |
Aathi, MS; Balasubramanian, M; Chilamakuru, NB; Dusthackeer, A; Mohanvel, SK; Munishankar, S; Nirmal, CR; Pandiya Raj, AK; Paraman, R; Rajadas, SE; Thiruvenkadam, K | 1 |
Reviews
1 review(s) available for inositol and rifampin
Article | Year |
---|---|
Mycothiol: a target for potentiation of rifampin and other antibiotics against Mycobacterium tuberculosis.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Cysteine; Drug Delivery Systems; Drug Synergism; Enzyme Inhibitors; Glycopeptides; Humans; Inositol; Mycobacterium tuberculosis; Rifampin | 2013 |
Other Studies
9 other study(ies) available for inositol and rifampin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Characterization of Mycobacterium smegmatis mutants defective in 1-d-myo-inosityl-2-amino-2-deoxy-alpha-d-glucopyranoside and mycothiol biosynthesis.
Topics: Culture Media; Cysteine; Disaccharides; Drug Resistance, Microbial; Genetic Complementation Test; Glucosides; Glycopeptides; Hydrogen Peroxide; Inositol; Isoniazid; Mutagenesis; Mycobacterium smegmatis; Pyrazoles; Rifampin; Sulfhydryl Compounds | 1999 |
Disruption of pathologic amyloid beta-protein fibril assembly on the surface of cultured human cerebrovascular smooth muscle cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cell Membrane; Cells, Cultured; Cerebral Amyloid Angiopathy; Humans; Inositol; Macromolecular Substances; Melatonin; Microscopy, Electron; Muscle, Smooth, Vascular; Rifampin; Rolitetracycline | 2001 |
Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics.
Topics: Amidohydrolases; Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; Benzene Derivatives; Catalase; Cell Division; Culture Media; Cysteine; Disaccharides; Drug Resistance, Multiple, Bacterial; Glycopeptides; Inositol; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Oleic Acid; Oxidants; Pyrazoles; Rifampin; Sulfhydryl Compounds | 2003 |
An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis suppurativa: our experience.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Clindamycin; Dietary Supplements; Drug Combinations; Drug Therapy, Combination; Energy Intake; Folic Acid; Glucose Intolerance; Hidradenitis Suppurativa; Humans; Inositol; Insulin Resistance; Liposomes; Magnesium; Metabolic Syndrome; Prevalence; Rifampin; Severity of Illness Index | 2020 |
Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein.
Topics: Antitubercular Agents; Bacterial Proteins; Cell Division; Cytoskeletal Proteins; Drug Synergism; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; In Vitro Techniques; Inositol; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium smegmatis; Mycobacterium tuberculosis; Plant Extracts; Plants, Medicinal; Rifampin; Temperature | 2020 |
Myoinositol and methyl stearate increases rifampicin susceptibility among drug-resistant Mycobacterium tuberculosis expressing Rv1819c.
Topics: Antitubercular Agents; Ellagic Acid; Humans; Inositol; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Stearates; Tuberculosis, Multidrug-Resistant | 2023 |